Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial

Bove, Tiziana, Zangrillo, Alberto, Guarracino, Fabio, Alvaro, Gabriele, Persi, Bruno, Maglioni, Enivarco, Galdieri, Nicola, Comis, Marco, Caramelli, Fabio, Pasero, Daniela C., Pala, Giovanni, Renzini, Massimo, Conte, Massimiliano, Paternoster, Gianluca, Martinez, Blanca, Pinelli, Fulvio, Frontini, Mario, Zucchetti, Maria C., Pappalardo, Federico, Amantea, Bruno, Camata, Annamaria, Pisano, Antonio, Verdecchia, Claudio, Dal Checco, Erika, Cariello, Claudia, Faita, Luana, Baldassarri, Rubia, Scandroglio, Anna M., Saleh, Omar, Lembo, Rosalba, Calabrò, Maria G., Bellomo, Rinaldo, Landoni, Giovanni·2014·JAMA

Abstract

IMPORTANCE: No effective pharmaceutical agents have yet been identified to treat acute kidney injury after cardiac surgery. OBJECTIVE: To determine whether fenoldopam reduces the need for renal replacement therapy in critically ill cardiac surgery patients with acute kidney injury. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, double-blind, placebo-controlled, parallel-group study from March 2008 to April 2013 in 19 cardiovascular intensive care units in Italy. We randomly assigned 667 patients admitted to intensive care units after cardiac surgery with early acute kidney injury (≥50% increase of serum creatinine level from baseline or oliguria for ≥6 hours) to receive fenoldopam (338 patients) or placebo (329 patients). We used a computer-generated permuted block randomization sequence for treatment allocation. All patients completed their follow-up 30 days after surgery, and data were analyzed according to the intention-to-treat principle. INTERVENTIONS: Continuous infusion of fenoldopam or placebo for up to 4 days with a starting dose of 0.1 μg/kg/min (range, 0.025-0.3 µg/kg/min). MAIN OUTCOMES AND MEASURES: The primary end point was the rate of renal replacement therapy. Secondary end points included mortality (intensive care unit and 30-day mortality) and the rate of hypotension during study drug infusion. RESULTS: The study was stopped for futility as recommended by the safety committee after a planned interim analysis. Sixty-nine of 338 patients (20%) allocated to the fenoldopam group and 60 of 329 patients (18%) allocated to the placebo group received renal replacement therapy (P = .47). Mortality at 30 days was 78 of 338 (23%) in the fenoldopam group and 74 of 329 (22%) in the placebo group (P = .86). Hypotension occurred in 85 (26%) patients in the fenoldopam group and in 49 (15%) patients in the placebo group (P = .001). CONCLUSIONS AND RELEVANCE: Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00621790.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2014.13573

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 181

Metadata

Authors
Bove, T., Zangrillo, A., Guarracino, F., Alvaro, G., Persi, B., Maglioni, E., Galdieri, N., Comis, M., Caramelli, F., Pasero, D. C., Pala, G., Renzini, M., Conte, M., Paternoster, G., Martinez, B., Pinelli, F., Frontini, M., Zucchetti, M. C., Pappalardo, F., Amantea, B., Camata, A., Pisano, A., Verdecchia, C., Dal Checco, E., Cariello, C., Faita, L., Baldassarri, R., Scandroglio, A. M., Saleh, O., Lembo, R., Calabrò, M. G., Bellomo, R., & Landoni, G.
Venue
JAMA
Published
2014-12-03
Volume
312
Issue
21
Pages
2244
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2008233785
Cited by
181
References
1
FWCI
16.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2014.13573
The paper
Bove, T., Zangrillo, A., Guarracino, F., Alvaro, G., Persi, B., Maglioni, E., Galdieri, N., Comis, M., Caramelli, F., Pasero, D. C., Pala, G., Renzini, M., Conte, M., Paternoster, G., Martinez, B., Pinelli, F., Frontini, M., Zucchetti, M. C., Pappalardo, F., . . . Landoni, G. (2014). Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2014.13573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.